The anti-proliferative effects of recombinant human lysozyme on human gastric cancer cells

Journal of International Medical Research

Volumn 35, Issue 3, 2007, Pages 353-360

  Guo, T K ^a,b   Zhao, X H ^c   Xie, Xiao Dong ^a   Chen, Z H ^d   Zhou, C S ^d   Wei, L L ^a   Zhang, H ^a  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c BEIJING UNION UNIVERSITY   (China)

^d Gansu Yasheng Industrial (Group) Co Ltd   (China)

Author keywords

Anti cancer agent; Human gastric cancer cell lines; Human lung fibroblasts; Recombinant human lysozyme

Indexed keywords

RECOMBINANT ENZYME; RECOMBINANT HUMAN LYSOZYME; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; DRUG TARGETING; ENZYME PURIFICATION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; MITOSIS INHIBITION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; STOMACH CANCER;

EID: 34250855094     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500310     Document Type: Article

References (31)

1. Osserman EF: Postulated relationships between lysozyme and immunoglobulins as mediators of macrophage and plasma cell functions. Adv Pathobiol 1976; 4: 98-100.
2. Gordon S, Todd J, Cohn ZA: In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med 1974; 139: 1228-1232.
3. Mason DY, Taylor CR: The distribution of lysozyme in human tissues. J Clin Pathol 1975; 28: 124-125.
4. Osserman EF, Lawlor DP: Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med 1966; 124: 921-951.
5. Deckx RJ, Vantrappen GR, Parein MM: Localization of lysozyme activity in a Paneth cell granule fraction. Biochim Biophys Acta 1967; 139: 204-207.
6. Tahara E, Ito H, Shimamoto F, et al: Lysozyme in human gastric carcinoma: a retrospective immunohistochemical study. Histopathology 1982; 6: 409-421.
7. Abe M, Yamashita S, Kuramoto T, et al: Global expression analysis of N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach carcinomas using oligonucleotide microarrays. Carcinogenesis 2003; 24: 861-867.
8. Wittekind C, Wachner R, Henke W, et al: Localization of CEA, HCG, lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in gastric cancer and prognosis. Virchows Arch A Pathol Anat Histopathol 1986; 409: 715-724.
9. Osserman EF, Canfield RE, Beychok S (eds): Lysozyme. New York: Academia Press, 1974.
10. Lee-Huang S, Huang PL, Sun YT: Lysozyme and RNase as anti-HIV components in β-core preparations of human chorionic gonadotropin. Proc Natl Acad Sci USA 1999; 96: 2678-2681.
11. Boesman-Finkelstein M, Finkelstein RA: Sequential purification of lactoferrin, lysozyme and secretory immunoglobulin A from human milk. FEBS Lett 1982; 144: 1-5.
12. Wang CS, Kloer HU: Purification of human lysozyme from milk and pancreatic juice. Anal Biochem 1984; 139: 224-227.
13. Huang J, Nandi S, Wu L, et al: Expression of natural antimicrobial human lysozyme in rice grains. Mol Breeding 2002; 10: 83-94.
14. Maga E, Anderson G, Cullor J, et al: Anti-microbial properties of human lysozyme: transgenic mouse milk. J Food Protect 1998; 61: 52-56.
15. Nakajima H, Muranaka T, Ishige F, et al: Fungal and bacterial disease resistance in transgenic plants expressing human lysozyme. Plant Cell Rep 1997; 16: 674-679.
16. Takaichi M, Oeda K: Transgenic carrots with enhanced resistance against two major pathogens, Erysiphe heraclei and Alternaria dauci. Plant Sci 2000; 25: 135-144.
17. Tsuchiya K, Tada S, Gomi K, et al: High level expression of the synthetic human lysozyme gene in Aspergillus oryzae. Appl Microbiol Biotechnol 1992; 38: 109-114.
18. Yoshimura K, Toibana A, Nakahama K: Human lysozyme: sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae. Biochem Biophys Res Commun 1988; 150: 794-801.
19. Tani XJ, Tanimura H, Yamawue H: Lysozyme enhances the tumoridical activity of tumor infiltration lymphocyte. Jpn J Cancer Ther 1992; 27: 288-291.
20. Sambrook J, Maniatis T, Fritsch EF: Molecular Cloning: a Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1989.
21. Huang J, Sutliff TD, Wu L, et al: Expression and purification of fungal human alpha-1-antitrypsin from cultured plant cells. Biotechnol Prog 2001; 17: 126-133.
22. Shugar D: Determination of lysozyme. Biochim Biophys Acta 1952; 8: 302-305.
23. Masayuki K, Tetsuji S, Rieko K, et al: Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis. Circ J 2006; 69: 1547-1555.
24. 6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer. Breast Cancer Res Treat 2003; 79: 301-312.
25. Li JX, Su SW, Mei HS, at al: Inhibition of valdecoxib on the proliferation of human gastric cancer cells. Chin Pharmacol Bull 2004; 20: 458-462.
26. Dai G, Huang C, Li Y, at al: Inhibitory effects of AcSDKP on proliferation of human bone marrow mesenchymal stem cells in vitro. Acta Physiol Sin 2006; 58:110-115.
27. Huang B, Zhao C, Lei X, et al: The cloning, sequencing anal analysis of Chinese human lysozyme gene CDNA amplified with RT-PCR from human placental total RNA. Sheng Wu Hua Hsueh Tsa Chih 1993; 9: 269-273.
28. Gao XY, Yuan SQ, Mu H, et al: Primary studies on the bacteriostasis and fungistasis of lysozyme from Raphanus sativus. J South China Agr Univ 1997; 18: 72-75.
29. Zhou ZW, Li MQ: Purification and enzymatic properties of the lysozyme from Brassica campestris L. ssp. chinensis var. utilis. Chin Biochem J 1994; 10: 367-370.
30. Luo LX, Yao RH, Huang ZR: Isolation and purification of lysozyme from Chinese oak silkworm pupae. Industrial Microbiol 1997; 27: 21-24.
31. Xia HH, Wong BC, Lam SK: Chemoprevention of gastric cancer: current status. Chin Med J 2003; 116: 5-10.